FREQUENTLY ASKED QUESTIONS
The Intelligent Design™ platform is our proprietary technology for single-cell functionomic analysis. It allows us to target disease specific immune functions with enhanced clarity and confidence, driving high-quality data generation and innovative therapeutic discoveries.
Pharmaceutical companies can collaborate with Feromics by utilizing our candidate optimization services for existing immunotherapy candidates, donor selection for allogeneic immunotherapies and developing custom projects based on your unique R&D needs. Our collaborative approach ensures seamless integration and accelerates therapeutics development.
Other companies rely on AI to decode immune cells omic (mRNA, DNA and protein) data but lack single-cell function-specific data required to drive powerful foundation models. Feromics uses proprietary single-cell technology to power our AI platform, providing more accurate mechanistic insight while requiring smaller sample and reducing time and costs.
Feromics generates its own samples using a binary assay system, leading to precise, high-quality data. We integrate this data with advanced AI and machine learning to decode mechanisms and provide actionable insights, ensuring high-confidence outcomes.
Feromics can develop a range of assets, including indication specific immunotherapy CAR-T, CAR-NK, CAR-Treg, bispecific antibodies and custom projects tailored to specific indications and approach. We also offer optimization services to enhance existing immunotherapy candidates and donor selection for allogeneic immunotherapies.